LCS16 vs. COC User Satisfaction and Tolerability Study
Condition:   Contraception Interventions:   Drug: Levonorgestrel (Kyleena, BAY86-5028);   Drug: Ethinyl estradiol and drospirenone (Yarina, BAY86-5131) Sponsor:   Bayer Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2017 Category: Research Source Type: clinical trials

Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
Conditions:   Primary Ovarian Insufficiency;   Menopause, PrematureIntervention:   Drug: Drospirenone and ethinyl estradiol combination (Yasmin)Sponsor:   Navy General Hospital, BeijingNot yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2016 Category: Research Source Type: clinical trials

Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition:   ContraceptionIntervention:   Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor:   BayerActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials

Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition:   ContraceptionIntervention:   Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor:   BayerActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials

Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition:   ContraceptionIntervention:   Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor:   BayerActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials

Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
Condition:   ContraceptionIntervention:   Drug: EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)Sponsor:   BayerActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 15, 2013 Category: Research Source Type: clinical trials

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
Condition:   Hidradenitis SuppurativaInterventions:   Drug: drospirenone and ethinyl estradiol (YAZ);   Drug: PlaceboSponsors:   Massachusetts General Hospital;   BayerTerminated - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2008 Category: Research Source Type: clinical trials

Treatment of Vasomotor Symptoms in Korean Post Menopausal Women
Condition:   Vasomotor SymptomsInterventions:   Drug: Angeliq (Drospirenone/17ß-estradiol, BAY86-4891);   Drug: PlaceboSponsor:   BayerCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2008 Category: Research Source Type: clinical trials

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Condition:   Vasomotor SymptomsInterventions:   Drug: Estradiol/DRSP (Angeliq, BAY86-4891);   Drug: PlaceboSponsor:   BayerCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2006 Category: Research Source Type: clinical trials